EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Beyond Avoidance: Advanced Therapies for Contact Dermatitis

Lu Yin, Benjamin Ungar, Emma Guttman-Yassky, David E Cohen, Theodora K Karagounis

The Journal of Allergy and Clinical Immunology: In Practice · 2024

DOI: 10.1016/j.jaip.2024.05.035 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2024. Verfasst von Lu Yin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, NY. Hauptthemen laut MEDLINE: Dermatitis, Allergic Contact. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Contact dermatitis (CD) is a common and burdensome condition divided into irritant contact dermatitis and allergic contact dermatitis. Treatment relies on accurate diagnosis and identification of the trigger, because definitive treatment is irritant or allergen avoidance. However, avoidance is not always possible, such as when the patient is reacting to a necessary medical device, when the trigger is integral to the patient's occupation, and when avoidance is practically untenable. In these cases, treatment is particularly challenging, especially because the literature on treatments in this clinical scenario is limited. In addition, CD has a complex pathophysiology that varies according to the trigger type, leading to variable treatment efficacy. This article reviews the current literature on treatments for CD with a focus on treatments when trigger avoidance is not feasible.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, Allergic ContactHumansAllergensDermatitis, IrritantDermatitis, Contact

Stichwörter der Autor:innen

Allergic contact dermatitisContact dermatitisDrugsIrritant contact dermatitisNovel therapies

Substanzen

Allergens

Autor:innen und Institutionen

  • Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, NY.
  • Kimberly and Eric J. Waldman Department of Dermatology, Icahn School of Medicine, Mount Sinai Medical Center and Health System, New York, NY.
  • Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, NY. Electronic address: theodora.karagounis@nyulangone.org.

Förderung

  • NIAMS NIH HHS
  • National Institutes of Health
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases

Zitieren

APA

Yin, L., Ungar, B., Guttman-Yassky, E., Cohen, D. E., & Karagounis, T. K. (2024). Beyond Avoidance: Advanced Therapies for Contact Dermatitis. The Journal of Allergy and Clinical Immunology: In Practice. https://doi.org/10.1016/j.jaip.2024.05.035

Vancouver

Yin L, Ungar B, Guttman-Yassky E, Cohen DE, Karagounis TK. Beyond Avoidance: Advanced Therapies for Contact Dermatitis. The Journal of Allergy and Clinical Immunology: In Practice. 2024. doi:10.1016/j.jaip.2024.05.035

BibTeX
@article{Yin2024,
  author = {Yin, Lu and Ungar, Benjamin and Guttman-Yassky, Emma and Cohen, David E and Karagounis, Theodora K},
  title = {Beyond Avoidance: Advanced Therapies for Contact Dermatitis},
  journal = {The Journal of Allergy and Clinical Immunology: In Practice},
  year = {2024},
  doi = {10.1016/j.jaip.2024.05.035}
}
Kostenlos starten →